HURA7:45 AMTuHURA Biosciences Reports Second Quarter 2026 Financial Results and Provides a Corporate Updatetuhurabio.com
HURA7:40 AMTuHURA Biosciences to Present at Canaccord Genuity's 46th Annual Growth Conferencetuhurabio.com
HURA7:45 AMTuHURA Biosciences Files Investigational New Drug Application for Evaluation of the TBS-2025 VISTA Inhibiting Antibody in Molecularly Defined Subsets of AML and Other Blood Related Cancerstuhurabio.com